Clinical Trial Update: Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating the combination of medroxyprogesterone acetate and a levonorgestrel-releasing intrauterine system (LNG-IUS) f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Mirena (levonorgestrel-releasing intrauterine system)
• Provera (medroxyprogesterone acetate)

Snippet

Sponsor: Korean Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: UNKNOWN